Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
2.230
-0.070 (-3.04%)
Aug 29, 2025, 4:00 PM - Market closed

Climb Bio Statistics

Total Valuation

Climb Bio has a market cap or net worth of $151.11 million. The enterprise value is -$35.65 million.

Market Cap151.11M
Enterprise Value -35.65M

Important Dates

The last earnings date was Tuesday, August 12, 2025, before market open.

Earnings Date Aug 12, 2025
Ex-Dividend Date n/a

Share Statistics

Climb Bio has 67.76 million shares outstanding. The number of shares has increased by 139.53% in one year.

Current Share Class 67.76M
Shares Outstanding 67.76M
Shares Change (YoY) +139.53%
Shares Change (QoQ) +0.18%
Owned by Insiders (%) 0.81%
Owned by Institutions (%) 27.22%
Float 25.58M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.81
P/TBV Ratio 0.81
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 14.08, with a Debt / Equity ratio of 0.00.

Current Ratio 14.08
Quick Ratio 13.65
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -22.92% and return on invested capital (ROIC) is -16.20%.

Return on Equity (ROE) -22.92%
Return on Assets (ROA) -15.83%
Return on Invested Capital (ROIC) -16.20%
Return on Capital Employed (ROCE) -28.46%
Revenue Per Employee n/a
Profits Per Employee -$2.60M
Employee Count18
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -64.03% in the last 52 weeks. The beta is -0.04, so Climb Bio's price volatility has been lower than the market average.

Beta (5Y) -0.04
52-Week Price Change -64.03%
50-Day Moving Average 1.61
200-Day Moving Average 1.72
Relative Strength Index (RSI) 63.09
Average Volume (20 Days) 886,105

Short Selling Information

The latest short interest is 1.12 million, so 1.65% of the outstanding shares have been sold short.

Short Interest 1.12M
Short Previous Month 1.31M
Short % of Shares Out 1.65%
Short % of Float 4.37%
Short Ratio (days to cover) 2.12

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -52.98M
Pretax Income n/a
Net Income -46.76M
EBITDA n/a
EBIT -52.98M
Earnings Per Share (EPS) -$0.69
Full Income Statement

Balance Sheet

The company has $84.70 million in cash and $639,000 in debt, giving a net cash position of $186.77 million or $2.76 per share.

Cash & Cash Equivalents 84.70M
Total Debt 639,000
Net Cash 186.77M
Net Cash Per Share $2.76
Equity (Book Value) 185.76M
Book Value Per Share 2.74
Working Capital 81.18M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$39.66 million and capital expenditures -$77,000, giving a free cash flow of -$39.74 million.

Operating Cash Flow -39.66M
Capital Expenditures -77,000
Free Cash Flow -39.74M
FCF Per Share -$0.59
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Climb Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -139.53%
Shareholder Yield n/a
Earnings Yield -30.94%
FCF Yield -26.29%

Analyst Forecast

The average price target for Climb Bio is $9.50, which is 326.01% higher than the current price. The consensus rating is "Buy".

Price Target $9.50
Price Target Difference 326.01%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1